Treatment of ventricular arrhythmias in patients with hypertrophic cardiomyopathy.
In patients with hypertrophic cardiomyopathy, asymptomatic episodes of non-sustained ventricular tachycardia are frequent and of prognostic significance for sudden cardiac death in adults, particularly in those whose consciousness is impaired. Low-dose amiodarone, found to be beneficial in mildly symptomatic non-sustained ventricular tachycardia, but detrimental in a subgroup with prominent non-arrhythmic symptoms, could be an alternative to an electrophysiological approach in patients with syncope but preserved functional capacity. In cardiac arrest survivors, an electrophysiological approach seems preferable to empiric amiodarone, together with implantation of a defibrillator, at least in those in whom inducible arrhythmias cannot be suppressed.
Almendral
J M
JM
Clinical Electrophysiology Laboratory, Hospital General Gregorio Marañón, Madrid, Spain.
Ormaetxe
J
J
Martínez-Alday
J D
JD
Villacastin
J P
JP
Arenal
A
A
Pastor
A
A
Medina
O
O
Peinado
R
R
Delcan
J L
JL
D000638:Amiodarone / Q000627:therapeutic use; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications*; D017147:Defibrillators, Implantable; D006801:Humans; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000628:therapy*
D000638:Amiodarone